Actavis and Adamas announced that the Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Namzaric (memantine HCl extended-release and donepezil HCl) capsules for the ...

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...

Among a small cohort of children and adolescents with autism spectrum disorder, a 12-week course of memantine led to improved social impairments based on standard metrics compared to placebo, data ...

According to Business Research Insights the Memantine Hydrochloride Tablets Market expected to exhibit a CAGR of 5.9% by 2033. The "Memantine Hydrochloride Tablets Market" Research is your essential ...

Forest Laboratories announced that it has submitted a New Drug Application (NDA) for a fixed-dose combination (FDC) of memantine HCl extended release (ER), a receptor antagonist and donepezil HCl, ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market Dr Reddy’s Laboratories has launched memantine hydrochloride tablets USP, 5 mg and 10 mg, a ...

The rising number of pipeline studies related to the use of memantine is expected to drive the memantine market growth. For instance, in September 2016, Lille University Hospital started phase I ...

United States Food & Drug Administration has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its abbreviated new drug application, it said, adding another 14 ANDAs are pending ...

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...